NIOX Group (LON:NIOX) Releases Quarterly Earnings Results

NIOX Group (LON:NIOX) posted its earnings results on Wednesday. The company reported GBX 1.41 earnings per share for the quarter, Digital Look Earnings reports. NIOX Group had a return on equity of 10.01% and a net margin of 14.74%.

NIOX Group Trading Up 0.3%

Shares of NIOX Group stock opened at GBX 69.20 on Thursday. The company has a market capitalization of £291.24 million, a P/E ratio of 42.20 and a beta of 0.92. The stock has a fifty day simple moving average of GBX 65.69 and a 200 day simple moving average of GBX 61.63. NIOX Group has a 12-month low of GBX 53.84 and a 12-month high of GBX 76. The company has a current ratio of 4.60, a quick ratio of 1.94 and a debt-to-equity ratio of 1.06.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.